Cargando…
Systematic Review of Available CAR-T Cell Trials around the World
SIMPLE SUMMARY: CAR-T cells are genetically modified T cells that are reprogrammed to specifically eliminate cancer cells. Due to its clinical success to treat certain hematological malignancies, novel approaches to improve CAR-T cell-based therapies are being explored. This systematic review gives...
Autores principales: | Barros, Luciana Rodrigues Carvalho, Couto, Samuel Campanelli Freitas, da Silva Santurio, Daniela, Paixão, Emanuelle Arantes, Cardoso, Fernanda, da Silva, Viviane Jennifer, Klinger, Paulo, Ribeiro, Paula do Amaral Costa, Rós, Felipe Augusto, Oliveira, Théo Gremen Mimary, Rego, Eduardo Magalhães, Ramos, Rodrigo Nalio, Rocha, Vanderson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179563/ https://www.ncbi.nlm.nih.gov/pubmed/35681646 http://dx.doi.org/10.3390/cancers14112667 |
Ejemplares similares
-
Myeloid Immune Cells CARrying a New Weapon Against Cancer
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2021) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies
por: Ramos, Rodrigo Nalio, et al.
Publicado: (2021) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation
por: Picanço-Castro, Virginia, et al.
Publicado: (2021) -
Compound Heterozygous SCN5A Mutations in a Toddler - Are they
Associated with a More Severe Phenotype?
por: Sacilotto, Luciana, et al.
Publicado: (2017) -
Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation
por: Paixão, Emanuelle A., et al.
Publicado: (2022)